PCA3 and prostate carcinoma: The Ruiz et al. (2010) group, who evaluated the detection of the PCA3 molecule in the diagnosis of prostate cancer, obtained a global diagnostic OR value of 5.59 (CI (3.96–7.89); Q = 57.30; p<0.0001).